KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Depreciation & Amortization (CF) (2016 - 2025)

Resmed (RMD) has disclosed Depreciation & Amortization (CF) for 17 consecutive years, with $49.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 7.42% year-over-year to $49.9 million, compared with a TTM value of $204.9 million through Dec 2025, up 14.9%, and an annual FY2025 reading of $198.5 million, up 12.21% over the prior year.
  • Depreciation & Amortization (CF) was $49.9 million for Q4 2025 at Resmed, up from $47.7 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $63.6 million in Q2 2025 and bottomed at $36.3 million in Q3 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $43.7 million, with a median of $43.7 million recorded in 2024.
  • The sharpest move saw Depreciation & Amortization (CF) decreased 7.41% in 2022, then soared 45.68% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $40.8 million in 2021, then fell by 7.41% to $37.8 million in 2022, then increased by 18.58% to $44.8 million in 2023, then rose by 3.7% to $46.4 million in 2024, then increased by 7.42% to $49.9 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for RMD at $49.9 million in Q4 2025, $47.7 million in Q3 2025, and $63.6 million in Q2 2025.